Sunday, September 27, 2009
Looks like Abbott have got Solvay in the bag
Abbott Pharmaceuticals plans to announce Monday a deal worth about $6.6 billion in cash to acquire the prescription drug unit of the Belgian company Solvay and take sole possession of their shared cholesterol drug venture, two people close to the discussions said Sunday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment